Ashley Bush

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Phenomena

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sensi Stefano L; Paoletti Pierre; Bush Ashley I; Sekler Israel
Zinc in the physiology and pathology of the CNS.
McColl Gawain; Roberts Blaine R; Gunn Adam P; Perez Keyla A; Tew Deborah J; Masters Colin L; Barnham Kevin J; Cherny Robert A; Bush Ashley I
The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42.
Hung Ya Hui; Robb Elysia L; Volitakis Irene; Ho Michael; Evin Genevieve; Li Qiao-Xin; Culvenor Janetta G; Masters Colin L; Cherny Robert A; Bush Ashley I
Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ashley Bush (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sensi Stefano L; Paoletti Pierre; Bush Ashley I; Sekler Israel
Zinc in the physiology and pathology of the CNS.
Nature reviews. Neuroscience 2009;10(11):780-91.
2009: McColl Gawain; Roberts Blaine R; Gunn Adam P; Perez Keyla A; Tew Deborah J; Masters Colin L; Barnham Kevin J; Cherny Robert A; Bush Ashley I
The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42.
The Journal of biological chemistry 2009;284(34):22697-702.
2009: Hung Ya Hui; Robb Elysia L; Volitakis Irene; Ho Michael; Evin Genevieve; Li Qiao-Xin; Culvenor Janetta G; Masters Colin L; Cherny Robert A; Bush Ashley I
Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease.
The Journal of biological chemistry 2009;284(33):21899-907.
2009: Ellis Kathryn A; Bush Ashley I; Darby David; De Fazio Daniela; Foster Jonathan; Hudson Peter; Lautenschlager Nicola T; Lenzo Nat; Martins Ralph N; Maruff Paul; Masters Colin; Milner Andrew; Pike Kerryn; Rowe Christopher; Savage Greg; Szoeke Cassandra; Taddei Kevin; Villemagne Victor; Woodward Michael; Ames David;
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
International psychogeriatrics / IPA 2009;21(4):672-87.
2009: Maynard Christa J; Cappai Roberto; Volitakis Irene; Laughton Katrina M; Masters Colin L; Bush Ashley I; Li Qiao-Xin
Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice.
Cellular and molecular neurobiology 2009;29(5):757-67.
2009: Strozyk Dorothea; Launer Lenore J; Adlard Paul A; Cherny Robert A; Tsatsanis Andrew; Volitakis Irene; Blennow Kaj; Petrovitch Helen; White Lon R; Bush Ashley I
Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.
Neurobiology of aging 2009;30(7):1069-77.
2009: White Carine; Kambe Taiho; Fulcher Yan G; Sachdev Sherri W; Bush Ashley I; Fritsche Kevin; Lee Jaekwon; Quinn Thomas P; Petris Michael J
Copper transport into the secretory pathway is regulated by oxygen in macrophages.
Journal of cell science 2009;122(Pt 9):1315-21.
2009: Adlard Paul A; James Simon A; Bush Ashley I; Masters Colin L
beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
Drugs of today (Barcelona, Spain : 1998) 2009;45(4):293-304.
2009: Grasso Giuseppe; Bush Ashley I; D'Agata Roberta; Rizzarelli Enrico; Spoto Giuseppe
Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme.
European biophysics journal : EBJ 2009;38(4):407-14.
2009: George J L; Mok S; Moses D; Wilkins S; Bush A I; Cherny R A; Finkelstein D I
Targeting the progression of Parkinson's disease.
Current neuropharmacology 2009;7(1):9-36.
2009: Dean Olivia; Bush Ashley I; Berk Michael; Copolov David L; van den Buuse Maarten
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice.
Behavioural brain research 2009;198(1):258-62.
2009: Crouch Peter J; Hung Lin Wai; Adlard Paul A; Cortes Mikhalina; Lal Varsha; Filiz Gulay; Perez Keyla A; Nurjono Milawaty; Caragounis Aphrodite; Du Tai; Laughton Katrina; Volitakis Irene; Bush Ashley I; Li Qiao-Xin; Masters Colin L; Cappai Roberto; Cherny Robert A; Donnelly Paul S; White Anthony R; Barnham Kevin J
Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(2):381-6.
2009: Biran Yif'at; Masters Colin L; Barnham Kevin J; Bush Ashley I; Adlard Paul A
Pharmacotherapeutic targets in Alzheimer's disease.
Journal of cellular and molecular medicine 2009;13(1):61-86.
2009: Smidt Kamille; Jessen Niels; Petersen Andreas Brønden; Larsen Agnete; Magnusson Nils; Jeppesen Johanne Bruun; Stoltenberg Meredin; Culvenor Janetta G; Tsatsanis Andrew; Brock Birgitte; Schmitz Ole; Wogensen Lise; Bush Ashley I; Rungby Jørgen
SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress.
PloS one 2009;4(5):e5684.
2008: Rogers Jack T; Bush Ashley I; Cho Hyan-Hee; Smith Deborah H; Thomson Andrew M; Friedlich Avi L; Lahiri Debomoy K; Leedman Peter J; Huang Xudong; Cahill Catherine M
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
Biochemical Society transactions 2008;36(Pt 6):1282-7.
2008: Wu Wei-hui; Lei Peng; Liu Qian; Hu Jia; Gunn Adam P; Chen Mei-sha; Rui Yan-fang; Su Xiao-yang; Xie Zuo-ping; Zhao Yu-Fen; Bush Ashley I; Li Yan-mei
Sequestration of copper from beta-amyloid promotes selective lysis by cyclen-hybrid cleavage agents.
The Journal of biological chemistry 2008;283(46):31657-64.
2008: Bush Ashley I
Drug development based on the metals hypothesis of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2008;15(2):223-40.
2008: Lannfelt Lars; Blennow Kaj; Zetterberg Henrik; Batsman Stellan; Ames David; Harrison John; Masters Colin L; Targum Steve; Bush Ashley I; Murdoch Ross; Wilson Janet; Ritchie Craig W;
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Lancet neurology 2008;7(9):779-86.
2008: Berk Michael; Copolov David L; Dean Olivia; Lu Kristy; Jeavons Sue; Schapkaitz Ian; Anderson-Hunt Murray; Bush Ashley I
N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Biological psychiatry 2008;64(6):468-75.
2008: Berk Michael; Copolov David; Dean Olivia; Lu Kristy; Jeavons Sue; Schapkaitz Ian; Anderson-Hunt Murray; Judd Fiona; Katz Fiona; Katz Paul; Ording-Jespersen Sean; Little John; Conus Philippe; Cuenod Michel; Do Kim Q; Bush Ashley I
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.
Biological psychiatry 2008;64(5):361-8.
2008: Ng Felicity; Berk Michael; Dean Olivia; Bush Ashley I
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(6):851-76.
2008: Lavoie Suzie; Murray Micah M; Deppen Patricia; Knyazeva Maria G; Berk Michael; Boulat Olivier; Bovet Pierre; Bush Ashley I; Conus Philippe; Copolov David; Fornari Eleonora; Meuli Reto; Solida Alessandra; Vianin Pascal; Cuénod Michel; Buclin Thierry; Do Kim Q
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(9):2187-99.
2008: Bush Ashley I; Tanzi Rudolph E
Therapeutics for Alzheimer's disease based on the metal hypothesis.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2008;5(3):421-32.
2008: Adlard Paul A; Cherny Robert A; Finkelstein David I; Gautier Elisabeth; Robb Elysia; Cortes Mikhalina; Volitakis Irene; Liu Xiang; Smith Jeffrey P; Perez Keyla; Laughton Katrina; Li Qiao-Xin; Charman Susan A; Nicolazzo Joseph A; Wilkins Simon; Deleva Karolina; Lynch Toni; Kok Gaik; Ritchie Craig W; Tanzi Rudolph E; Cappai Roberto; Masters Colin L; Barnham Kevin J; Bush Ashley I
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
Neuron 2008;59(1):43-55.
2008: Berk Michael; Ng Felicity; Dean Olivia; Dodd Seetal; Bush Ashley I
Glutathione: a novel treatment target in psychiatry.
Trends in pharmacological sciences 2008;29(7):346-51.
2008: Barnham Kevin J; Kenche Vijaya B; Ciccotosto Giuseppe D; Smith David P; Tew Deborah J; Liu Xiang; Perez Keyla; Cranston Greg A; Johanssen Timothy J; Volitakis Irene; Bush Ashley I; Masters Colin L; White Anthony R; Smith Jeffrey P; Cherny Robert A; Cappai Roberto
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(19):6813-8.
2008: Du Tai; La Fontaine Sharon L; Abdo Michael; Bellingham Shayne A; Greenough Mark; Volitakis Irene; Cherny Robert A; Bush Ashley I; Hudson Peter J; Camakaris James; Mercer Julian F; Crouch Peter J; Masters Colin L; Perreau Victoria M; White Anthony R
Investigating copper-regulated protein expression in Menkes fibroblasts using antibody microarrays.
Proteomics 2008;8(9):1819-31.
2008: Cater Michael A; McInnes Kelly T; Li Qiao-Xin; Volitakis Irene; La Fontaine Sharon; Mercer Julian F B; Bush Ashley I
Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
The Biochemical journal 2008;412(1):141-52.
2008: Barnham Kevin J; Bush Ashley I
Metals in Alzheimer's and Parkinson's diseases.
Current opinion in chemical biology 2008;12(2):222-8.
2008: Colvin Robert A; Bush Ashley I; Volitakis Irene; Fontaine Charles P; Thomas Dustin; Kikuchi Kazuya; Holmes William R
Insights into Zn2+ homeostasis in neurons from experimental and modeling studies.
American journal of physiology. Cell physiology 2008;294(3):C726-42.
2008: Bush Ashley I; Curtain Cyril C
Twenty years of metallo-neurobiology: where to now?
European biophysics journal : EBJ 2008;37(3):241-5.
2008: Nagano Seiichi; Bush Ashley I
Sensitive, selective, and irreversible inhibition of cyclooxygenase-2 activity by copper.
ChemMedChem 2008;3(2):223-5.
2008: Crouch Peter J; Harding Susan-Marie E; White Anthony R; Camakaris James; Bush Ashley I; Masters Colin L
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
The international journal of biochemistry & cell biology 2008;40(2):181-98.
2007: Stoltenberg M; Bush A I; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
Neuroscience 2007;150(2):357-69.
2007: Crouch P J; Cimdins K; Duce J A; Bush A I; Trounce I A
Mitochondria in aging and Alzheimer's disease.
Rejuvenation research 2007;10(3):349-57.
2007: Crouch Peter J; White Anthony R; Bush Ashley I
The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
The FEBS journal 2007;274(15):3775-83.
2007: Watanabe Shohei; Nagano Seiichi; Duce James; Kiaei Mahmoud; Li Qiao-Xin; Tucker Stephanie M; Tiwari Ashutosh; Brown Robert H; Beal M Flint; Hayward Lawrence J; Culotta Valeria C; Yoshihara Satoshi; Sakoda Saburo; Bush Ashley I
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Free radical biology & medicine 2007;42(10):1534-42.
2007: Melov Simon; Adlard Paul A; Morten Karl; Johnson Felicity; Golden Tamara R; Hinerfeld Doug; Schilling Birgit; Mavros Christine; Masters Colin L; Volitakis Irene; Li Qiao-Xin; Laughton Katrina; Hubbard Alan; Cherny Robert A; Gibson Brad; Bush Ashley I
Mitochondrial oxidative stress causes hyperphosphorylation of tau.
PloS one 2007;2(6):e536.
2007: Fox Jonathan H; Kama Jibrin A; Lieberman Gregory; Chopra Raman; Dorsey Kate; Chopra Vanita; Volitakis Irene; Cherny Robert A; Bush Ashley I; Hersch Steven
Mechanisms of copper ion mediated Huntington's disease progression.
PloS one 2007;2(3):e334.
2006: Adlard Paul A; Bush Ashley I
Metals and Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2006;10(2-3):145-63.
2006: Crouch Peter J; Barnham Kevin J; Bush Ashley I; White Anthony R
Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
Drug news & perspectives 2006;19(8):469-74.
2006: Tucker Stephanie; Ahl Michelle; Cho Hyun-Hee; Bandyopadhyay Sanghamitra; Cuny Gregory D; Bush Ashley I; Goldstein Lee E; Westaway David; Huang Xudong; Rogers Jack T
RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine.
Current Alzheimer research 2006;3(3):221-7.
2006: Religa D; Strozyk D; Cherny R A; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush A I
Elevated cortical zinc in Alzheimer disease.
Neurology 2006;67(1):69-75.
2006: White Anthony R; Du Tai; Laughton Katrina M; Volitakis Irene; Sharples Robyn A; Xilinas Michel E; Hoke David E; Holsinger R M Damian; Evin Geneviève; Cherny Robert A; Hill Andrew F; Barnham Kevin J; Li Qiao-Xin; Bush Ashley I; Masters Colin L
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity.
The Journal of biological chemistry 2006;281(26):17670-80.
2006: Smith David P; Smith Danielle G; Curtain Cyril C; Boas John F; Pilbrow John R; Ciccotosto Giuseppe D; Lau Tong-Lay; Tew Deborah J; Perez Keyla; Wade John D; Bush Ashley I; Drew Simon C; Separovic Frances; Masters Colin L; Cappai Roberto; Barnham Kevin J
Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge.
The Journal of biological chemistry 2006;281(22):15145-54.
2006: White Anthony R; Barnham Kevin J; Bush Ashley I
Metal homeostasis in Alzheimer's disease.
Expert review of neurotherapeutics 2006;6(5):711-22.
2006: Maynard Christa J; Cappai Roberto; Volitakis Irene; Cherny Robert A; Masters Colin L; Li Qiao-Xin; Bush Ashley I
Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
Journal of inorganic biochemistry 2006;100(5-6):952-62.
2006: Opazo Carlos; Luza Sandra; Villemagne Victor L; Volitakis Irene; Rowe Christopher; Barnham Kevin J; Strozyk Dorothea; Masters Colin L; Cherny Robert A; Bush Ashley I
Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
Aging cell 2006;5(1):69-79.
2005: Haeffner Fredrik; Smith Danielle G; Barnham Kevin J; Bush Ashley I
Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.
Journal of inorganic biochemistry 2005;99(12):2403-22.
2005: Siddiq Ambreena; Ayoub Issam A; Chavez Juan C; Aminova Leila; Shah Sapan; LaManna Joseph C; Patton Stephanie M; Connor James R; Cherny Robert A; Volitakis Irene; Bush Ashley I; Langsetmo Ingrid; Seeley Todd; Gunzler Volkmar; Ratan Rajiv R
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.
The Journal of biological chemistry 2005;280(50):41732-43.
2005: Puglielli Luigi; Friedlich Avi L; Setchell Kenneth D R; Nagano Seiichi; Opazo Carlos; Cherny Robert A; Barnham Kevin J; Wade John D; Melov Simon; Kovacs Dora M; Bush Ashley I
Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.
The Journal of clinical investigation 2005;115(9):2556-63.
2005: Maynard Christa J; Bush Ashley I; Masters Colin L; Cappai Roberto; Li Qiao-Xin
Metals and amyloid-beta in Alzheimer's disease.
International journal of experimental pathology 2005;86(3):147-59.
2005: Frederickson Christopher J; Koh Jae-Young; Bush Ashley I
The neurobiology of zinc in health and disease.
Nature reviews. Neuroscience 2005;6(6):449-62.
2005: Ali Feda E; Separovic Frances; Barrow Colin J; Cherny Robert A; Fraser Fiona; Bush Ashley I; Masters Colin L; Barnham Kevin J
Methionine regulates copper/hydrogen peroxide oxidation products of Abeta.
Journal of peptide science : an official publication of the European Peptide Society 2005;11(6):353-60.
2005: Tucker Stephanie; Ahl Michelle; Bush Ashley; Westaway David; Huang Xudong; Rogers Jack T
Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region.
Current Alzheimer research 2005;2(2):249-54.
2005: Tickler Anna K; Smith Danielle G; Ciccotosto Giuseppe D; Tew Deborah J; Curtain Cyril C; Carrington Darryl; Masters Colin L; Bush Ashley I; Cherny Robert A; Cappai Roberto; Wade John D; Barnham Kevin J
Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.
The Journal of biological chemistry 2005;280(14):13355-63.
2005: Melov Simon; Wolf Norman; Strozyk Dorothea; Doctrow Susan R; Bush Ashley I
Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment.
Free radical biology & medicine 2005;38(2):258-61.
2005: Cuajungco Math P; Frederickson Christopher J; Bush Ashley I
Amyloid-beta metal interaction and metal chelation.
Sub-cellular biochemistry 2005;38():235-54.
2004: Venti Amanda; Giordano Tony; Eder Paul; Bush Ashley I; Lahiri Debomoy K; Greig Nigel H; Rogers Jack T
The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Annals of the New York Academy of Sciences 2004;1035():34-48.
2004: Huang Xudong; Atwood Craig S; Moir Robert D; Hartshorn Mariana A; Tanzi Rudolph E; Bush Ashley I
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2004;9(8):954-60.
2004: Ritchie Craig W; Bush Ashley I; Masters Colin L
Metal-protein attenuating compounds and Alzheimer's disease.
Expert opinion on investigational drugs 2004;13(12):1585-92.
2004: Dedeoglu Alpaslan; Cormier Kerry; Payton Sandra; Tseitlin Katya A; Kremsky Jonathan N; Lai Li; Li Xiaohua; Moir Robert D; Tanzi Rudolph E; Bush Ashley I; Kowall Neil W; Rogers Jack T; Huang Xudong
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
Experimental gerontology 2004;39(11-12):1641-9.
2004: Cerpa Waldo F; Barría María I; Chacón Marcelo A; Suazo Miriam; González Mauricio; Opazo Carlos; Bush Ashley I; Inestrosa Nibaldo C
The N-terminal copper-binding domain of the amyloid precursor protein protects against Cu2+ neurotoxicity in vivo.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(14):1701-3.
2004: Ciccotosto Giuseppe D; Tew Deborah; Curtain Cyril C; Smith Danielle; Carrington Darryl; Masters Colin L; Bush Ashley I; Cherny Robert A; Cappai Roberto; Barnham Kevin J
Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution.
The Journal of biological chemistry 2004;279(41):42528-34.
2004: Kiaei Mahmoud; Bush Ashley I; Morrison Brett M; Morrison John H; Cherny Robert A; Volitakis Irene; Beal M Flint; Gordon Jon W
Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(36):7945-50.
2004: Barnham Kevin J; Haeffner Fredrik; Ciccotosto Giuseppe D; Curtain Cyril C; Tew Deborah; Mavros Christine; Beyreuther Konrad; Carrington Darryl; Masters Colin L; Cherny Robert A; Cappai Roberto; Bush Ashley I
Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(12):1427-9.
2004: Butterfield D Allan; Bush Ashley I
Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide.
Neurobiology of aging 2004;25(5):563-8.
2004: Bush Ashley I; Strozyk Dorothea
Serum copper: a biomarker for Alzheimer disease?
Archives of neurology 2004;61(5):631-2.
2004: Yao Shenggen; Cherny Robert A; Bush Ashley I; Masters Colin L; Barnham Kevin J
Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
Journal of peptide science : an official publication of the European Peptide Society 2004;10(4):210-7.
2004: White Anthony R; Barnham Kevin J; Huang Xudong; Voltakis Irene; Beyreuther Konrad; Masters Colin L; Cherny Robert A; Bush Ashley I; Cappai Roberto
Iron inhibits neurotoxicity induced by trace copper and biological reductants.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2004;9(3):269-80.
2004: Nagano Seiichi; Huang Xudong; Moir Robert D; Payton Sandra M; Tanzi Rudolph E; Bush Ashley I
Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease.
The Journal of biological chemistry 2004;279(15):14673-8.
2004: Huang Xudong; Moir Robert D; Tanzi Rudolph E; Bush Ashley I; Rogers Jack T
Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Annals of the New York Academy of Sciences 2004;1012():153-63.
2004: Friedlich Avi L; Lee Joo-Yong; van Groen Thomas; Cherny Robert A; Volitakis Irene; Cole Toby B; Palmiter Richard D; Koh Jae-Young; Bush Ashley I
Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(13):3453-9.
2004: Barnham Kevin J; Masters Colin L; Bush Ashley I
Neurodegenerative diseases and oxidative stress.
Nature reviews. Drug discovery 2004;3(3):205-14.
2004: Lee Joo-Yong; Kim Jung-Hwan; Hong Seok Ho; Lee Ji Yoon; Cherny Robert A; Bush Ashley I; Palmiter Richard D; Koh Jae-Young
Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain.
The Journal of biological chemistry 2004;279(10):8602-7.
2004: Atwood Craig S; Perry George; Zeng Hong; Kato Yoji; Jones Walton D; Ling Ke-Qing; Huang Xudong; Moir Robert D; Wang Dandan; Sayre Lawrence M; Smith Mark A; Chen Shu G; Bush Ashley I
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Biochemistry 2004;43(2):560-8.
2003: Ritchie Craig W; Bush Ashley I; Mackinnon Andrew; Macfarlane Steve; Mastwyk Maree; MacGregor Lachlan; Kiers Lyn; Cherny Robert; Li Qiao-Xin; Tammer Amanda; Carrington Darryl; Mavros Christine; Volitakis Irene; Xilinas Michel; Ames David; Davis Stephen; Beyreuther Konrad; Tanzi Rudolph E; Masters Colin L
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
Archives of neurology 2003;60(12):1685-91.
2003: Barnham Kevin J; Ciccotosto Giuseppe D; Tickler Anna K; Ali Feda E; Smith Danielle G; Williamson Nicholas A; Lam Yuen-Han; Carrington Darryl; Tew Deborah; Kocak Gulcan; Volitakis Irene; Separovic Frances; Barrow Colin J; Wade John D; Masters Colin L; Cherny Robert A; Curtain Cyril C; Bush Ashley I; Cappai Roberto
Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.
The Journal of biological chemistry 2003;278(44):42959-65.
2003: Bush Ashley I; Masters Colin L; Tanzi Rudolph E
Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11193-4.
2003: Finefrock Anne E; Bush Ashley I; Doraiswamy P Murali
Current status of metals as therapeutic targets in Alzheimer's disease.
Journal of the American Geriatrics Society 2003;51(8):1143-8.
2003: Bush Ashley I
Copper, zinc, and the metallobiology of Alzheimer disease.
Alzheimer disease and associated disorders 2003;17(3):147-50.
2003: Goldstein Lee E; Muffat Julien A; Cherny Robert A; Moir Robert D; Ericsson Maria H; Huang Xudong; Mavros Christine; Coccia Jennifer A; Faget Kyle Y; Fitch Karlotta A; Masters Colin L; Tanzi Rudolph E; Chylack Leo T; Bush Ashley I
Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
Lancet 2003;361(9365):1258-65.
2003: Bush Ashley I
The metallobiology of Alzheimer's disease.
Trends in neurosciences 2003;26(4):207-14.
2003: Kaur Deepinder; Yantiri Ferda; Rajagopalan Subramanian; Kumar Jyothi; Mo Jun Qin; Boonplueang Rapee; Viswanath Veena; Jacobs Russell; Yang Lichuan; Beal M Flint; DiMonte Dino; Volitaskis Irene; Ellerby Lisa; Cherny Robert A; Bush Ashley I; Andersen Julie K
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
Neuron 2003;37(6):899-909.
2003: Curtain Cyril C; Ali Fedá E; Smith Danielle G; Bush Ashley I; Masters Colin L; Barnham Kevin J
Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid.
The Journal of biological chemistry 2003;278(5):2977-82.
2002: Bush Ashley I
Metal complexing agents as therapies for Alzheimer's disease.
Neurobiology of aging 2002;23(6):1031-8.
2002: Maynard Christa J; Cappai Roberto; Volitakis Irene; Cherny Robert A; White Anthony R; Beyreuther Konrad; Masters Colin L; Bush Ashley I; Li Qiao-Xin
Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.
The Journal of biological chemistry 2002;277(47):44670-6.
2002: Rogers Jack T; Randall Jeffrey D; Cahill Catherine M; Eder Paul S; Huang Xudong; Gunshin Hiromi; Leiter Lorene; McPhee Jay; Sarang Satinder S; Utsuki Tada; Greig Nigel H; Lahiri Debomoy K; Tanzi Rudolph E; Bush Ashley I; Giordano Tony; Gullans Steve R
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
The Journal of biological chemistry 2002;277(47):45518-28.
2002: Bush Ashley I
Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?
Nature neuroscience 2002;5(10):919; author reply 919-20.
2002: Opazo Carlos; Huang Xudong; Cherny Robert A; Moir Robert D; Roher Alex E; White Anthony R; Cappai Roberto; Masters Colin L; Tanzi Rudolph E; Inestrosa Nibaldo C; Bush Ashley I
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).
The Journal of biological chemistry 2002;277(43):40302-8.
2002: Rogers Jack T; Randall Jeffrey D; Eder Paul S; Huang Xudong; Bush Ashley I; Tanzi Rudolph E; Venti Amanda; Payton Sandra M; Giordano Tony; Nagano Seiichi; Cahill Catherine M; Moir Robert; Lahiri Debomoy K; Greig Nigel; Sarang Satinder Singh; Gullans Steven R
Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.
Journal of molecular neuroscience : MN 2002;19(1-2):77-82.
2002: Bush Ashley I; Tanzi Rudolph E
The galvanization of beta-amyloid in Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7317-9.
2001: Frederickson C J; Bush A I
Synaptically released zinc: physiological functions and pathological effects.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2001;14(3-4):353-66.
2001: Jobling M F; Huang X; Stewart L R; Barnham K J; Curtain C; Volitakis I; Perugini M; White A R; Cherny R A; Masters C L; Barrow C J; Collins S J; Bush A I; Cappai R
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Biochemistry 2001;40(27):8073-84.
2001: Cherny R A; Atwood C S; Xilinas M E; Gray D N; Jones W D; McLean C A; Barnham K J; Volitakis I; Fraser F W; Kim Y; Huang X; Goldstein L E; Moir R D; Lim J T; Beyreuther K; Zheng H; Tanzi R E; Masters C L; Bush A I
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
Neuron 2001;30(3):665-76.
2001: Curtain C C; Ali F; Volitakis I; Cherny R A; Norton R S; Beyreuther K; Barrow C J; Masters C L; Bush A I; Barnham K J
Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits.
The Journal of biological chemistry 2001;276(23):20466-73.
2001: White A R; Huang X; Jobling M F; Barrow C J; Beyreuther K; Masters C L; Bush A I; Cappai R
Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways.
Journal of neurochemistry 2001;76(5):1509-20.
2001: Rottkamp C A; Raina A K; Zhu X; Gaier E; Bush A I; Atwood C S; Chevion M; Perry G; Smith M A
Redox-active iron mediates amyloid-beta toxicity.
Free radical biology & medicine 2001;30(4):447-50.
2001: Bush A I; Goldstein L E
Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts.
Novartis Foundation symposium 2001;235():26-38; discussion 38-43.
2000: Atwood C S; Scarpa R C; Huang X; Moir R D; Jones W D; Fairlie D P; Tanzi R E; Bush A I
Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.
Journal of neurochemistry 2000;75(3):1219-33.
2000: Andreassen O A; Dedeoglu A; Klivenyi P; Beal M F; Bush A I
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis.
Neuroreport 2000;11(11):2491-3.
2000: Lynch T; Cherny R A; Bush A I
Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.
Experimental gerontology 2000;35(4):445-51.
2000: Cherny R A; Barnham K J; Lynch T; Volitakis I; Li Q X; McLean C A; Multhaup G; Beyreuther K; Tanzi R E; Masters C L; Bush A I
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Journal of structural biology 2000;130(2-3):209-16.
2000: Atwood C S; Huang X; Khatri A; Scarpa R C; Kim Y S; Moir R D; Tanzi R E; Roher A E; Bush A I
Copper catalyzed oxidation of Alzheimer Abeta.
Cellular and molecular biology (Noisy-le-Grand, France) 2000;46(4):777-83.
2000: Goldstein L E; Leopold M C; Huang X; Atwood C S; Saunders A J; Hartshorn M; Lim J T; Faget K Y; Muffat J A; Scarpa R C; Chylack L T; Bowden E F; Tanzi R E; Bush A I
3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction.
Biochemistry 2000;39(24):7266-75.
2000: Cuajungco M P; Goldstein L E; Nunomura A; Smith M A; Lim J T; Atwood C S; Huang X; Farrag Y W; Perry G; Bush A I
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
The Journal of biological chemistry 2000;275(26):19439-42.
2000: Huang X; Cuajungco M P; Atwood C S; Moir R D; Tanzi R E; Bush A I
Alzheimer's disease, beta-amyloid protein and zinc.
The Journal of nutrition 2000;130(5S Suppl):1488S-92S.
2000: Bush A I
Metals and neuroscience.
Current opinion in chemical biology 2000;4(2):184-91.
2000: Cuajungco M P; Fagét K Y; Huang X; Tanzi R E; Bush A I
Metal chelation as a potential therapy for Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;920():292-304.
1999: Huang X; Cuajungco M P; Atwood C S; Hartshorn M A; Tyndall J D; Hanson G R; Stokes K C; Leopold M; Multhaup G; Goldstein L E; Scarpa R C; Saunders A J; Lim J; Moir R D; Glabe C; Bowden E F; Masters C L; Fairlie D P; Tanzi R E; Bush A I
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.
The Journal of biological chemistry 1999;274(52):37111-6.
1999: McLean C A; Cherny R A; Fraser F W; Fuller S J; Smith M J; Beyreuther K; Bush A I; Masters C L
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.
Annals of neurology 1999;46(6):860-6.
1999: White A R; Multhaup G; Maher F; Bellingham S; Camakaris J; Zheng H; Bush A I; Beyreuther K; Masters C L; Cappai R
The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(21):9170-9.
1999: White A R; Reyes R; Mercer J F; Camakaris J; Zheng H; Bush A I; Multhaup G; Beyreuther K; Masters C L; Cappai R
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice.
Brain research 1999;842(2):439-44.
1999: Cherny R A; Legg J T; McLean C A; Fairlie D P; Huang X; Atwood C S; Beyreuther K; Tanzi R E; Masters C L; Bush A I
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
The Journal of biological chemistry 1999;274(33):23223-8.
1999: Moir R D; Atwood C S; Huang X; Tanzi R E; Bush A I
Mounting evidence for the involvement of zinc and copper in Alzheimer's disease.
European journal of clinical investigation 1999;29(7):569-70.
1999: Huang X; Atwood C S; Hartshorn M A; Multhaup G; Goldstein L E; Scarpa R C; Cuajungco M P; Gray D N; Lim J; Moir R D; Tanzi R E; Bush A I
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.
Biochemistry 1999;38(24):7609-16.
1999: Li Q X; Maynard C; Cappai R; McLean C A; Cherny R A; Lynch T; Culvenor J G; Trevaskis J; Tanner J E; Bailey K A; Czech C; Bush A I; Beyreuther K; Masters C L
Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice.
Journal of neurochemistry 1999;72(6):2479-87.
1999: White A R; Bush A I; Beyreuther K; Masters C L; Cappai R
Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione.
Journal of neurochemistry 1999;72(5):2092-8.
1999: Moir R D; Atwood C S; Romano D M; Laurans M H; Huang X; Bush A I; Smith J D; Tanzi R E
Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.
Biochemistry 1999;38(14):4595-603.
1999: Atwood C S; Huang X; Moir R D; Tanzi R E; Bush A I
Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
Metal ions in biological systems 1999;36():309-64.
1998: Wolozin B; Maheshwari S; Jones C; Dukoff R; Wallace W; Racchi M; Nagula S; Shulman N R; Sunderland T; Bush A
Beta-amyloid augments platelet aggregation: reduced activity of familial angiopathy-associated mutants.
Molecular psychiatry 1998;3(6):500-7.
1998: Bush A I; Tanzi R E
Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelet: the brain's delegate in the periphery?
Archives of neurology 1998;55(9):1179-80.
1998: Atwood C S; Moir R D; Huang X; Scarpa R C; Bacarra N M; Romano D M; Hartshorn M A; Tanzi R E; Bush A I
Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.
The Journal of biological chemistry 1998;273(21):12817-26.
1998: Moir R D; Lynch T; Bush A I; Whyte S; Henry A; Portbury S; Multhaup G; Small D H; Tanzi R E; Beyreuther K; Masters C L
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
The Journal of biological chemistry 1998;273(9):5013-9.
1998: Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush A M; Moir R; Tanzi R E; Growdon J H; Nitsch R M
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
European neurology 1998;39(2):111-8.
1997: Huang X; Atwood C S; Moir R D; Hartshorn M A; Vonsattel J P; Tanzi R E; Bush A I
Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.
The Journal of biological chemistry 1997;272(42):26464-70.
1997: Aschner M; Cherian M G; Klaassen C D; Palmiter R D; Erickson J C; Bush A I
Metallothioneins in brain--the role in physiology and pathology.
Toxicology and applied pharmacology 1997;142(2):229-42.
1995: Kounnas M Z; Moir R D; Rebeck G W; Bush A I; Argraves W S; Tanzi R E; Hyman B T; Strickland D K
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation.
Cell 1995;82(2):331-40.
1994: Multhaup G; Bush A I; Pollwein P; Masters C L
Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP).
FEBS letters 1994;355(2):151-4.
1994: Bush A I; Pettingell W H; de Paradis M; Tanzi R E; Wasco W
The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily.
The Journal of biological chemistry 1994;269(43):26618-21.
1994: Bush A I; Pettingell W H; Multhaup G; d Paradis M; Vonsattel J P; Gusella J F; Beyreuther K; Masters C L; Tanzi R E
Rapid induction of Alzheimer A beta amyloid formation by zinc.
Science (New York, N.Y.) 1994;265(5177):1464-7.
1994: Li Q X; Berndt M C; Bush A I; Rumble B; Mackenzie I; Friedhuber A; Beyreuther K; Masters C L
Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet.
Blood 1994;84(1):133-42.
1994: Bush A I; Pettingell W H; Paradis M D; Tanzi R E
Modulation of A beta adhesiveness and secretase site cleavage by zinc.
The Journal of biological chemistry 1994;269(16):12152-8.
1994: Tanzi R E; Bush A I; Wasco W
Genetic studies of Alzheimer's disease: lessons learned and future imperatives.
Neurobiology of aging 1994;15 Suppl 2():S145-8.
1993: Bush A I; Beyreuther K; Masters C L
The beta A4 amyloid protein precursor in human circulation.
Annals of the New York Academy of Sciences 1993;695():175-82.
1993: Bush A I; Multhaup G; Moir R D; Williamson T G; Small D H; Rumble B; Pollwein P; Beyreuther K; Masters C L
A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease.
The Journal of biological chemistry 1993;268(22):16109-12.
1993: Tanzi R; Gaston S; Bush A; Romano D; Pettingell W; Peppercorn J; Paradis M; Gurubhagavatula S; Jenkins B; Wasco W
Genetic heterogeneity of gene defects responsible for familial Alzheimer disease.
Genetica 1993;91(1-3):255-63.
1992: Moir R D; Martins R N; Bush A I; Small D H; Milward E A; Rumble B A; Multhaup G; Beyreuther K; Masters C L
Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization.
Journal of neurochemistry 1992;59(4):1490-8.
1992: Bush A I; Whyte S; Thomas L D; Williamson T G; Van Tiggelen C J; Currie J; Small D H; Moir R D; Li Q X; Rumble B
An abnormality of plasma amyloid protein precursor in Alzheimer's disease.
Annals of neurology 1992;32(1):57-65.
1992: Bush A I; Beyreuther K; Masters C L
Beta A4 amyloid protein and its precursor in Alzheimer's disease.
Pharmacology & therapeutics 1992;56(1):97-117.
1991: Small D H; Moir R D; Fuller S J; Michaelson S; Bush A I; Li Q X; Milward E; Hilbich C; Weidemann A; Beyreuther K
A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.
Biochemistry 1991;30(44):10795-9.
1991: Beyreuther K; Bush A I; Dyrks T; Hilbich C; König G; Mönning U; Multhaup G; Prior R; Rumble B; Schubert W
Mechanisms of amyloid deposition in Alzheimer's disease.
Annals of the New York Academy of Sciences 1991;640():129-39.
1990: Bush A I; Martins R N; Rumble B; Moir R; Fuller S; Milward E; Currie J; Ames D; Weidemann A; Fischer P
The amyloid precursor protein of Alzheimer's disease is released by human platelets.
The Journal of biological chemistry 1990;265(26):15977-83.
1990: Bush A I; Huang W; Copolov D L; Lim A T
Hypothalamic atrial natriuretic peptide secretion plasticity: differential modulation of alpha and beta adrenoceptors.
Neuroendocrinology 1990;52(1):65-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ashley Bush

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ashley Bush (preview)

All Publications